Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

Gene therapy for deafness moves closer

13 July 2015

By Dr Greg Ball

Appeared in BioNews 810

A technique that delivers genes into the inner ears of mice has been used to restore hearing, marking the first time that gene therapy has been successfully used to treat deafness.

The study, published in Science Translational Medicine, focused on mice with deafness caused by the TMC1 gene. TMC1 is one of over 70 genes known to cause hereditary deafness, and accounts for four to eight percent of hereditary deafness cases in humans. When both copies are missing in humans, it results in profound hearing loss by around the age of two.

The technique harnesses the natural ability of viruses to transfer viral genes into cells. The scientists hijacked this ability to deliver genes into the sensory cells of the ear that transmit sound signals to the brain. Each virus was modified so that it carried a working copy of the TMC1 gene and was no longer infectious. The viruses were then injected into the inner ears of mice that were missing both copies of TMC1.

The scientists measured nerve signals between the ear and the brain, and found that these signals were restored following treatment with viruses carrying the TMC1 gene.

More importantly, the mice regained a normal response to loud noises following treatment, confirming that the nerves were working correctly. The mice were placed into a 'startle box', where sudden, loud sounds are emitted.

'Mice with TMC1 mutations will just sit there, but with gene therapy they jump as high as a normal mouse,' said Dr Jeffrey Holt of Boston Children's Hospital and Harvard Medical School, who led the study.

The researchers also tested the technique in mice who did have the TMC1 gene but a version with a mutation – a model for a condition in humans that causes deafness by around adolescence. In these mice, gene therapy with TMC2 – a gene closely related to TMC1 – resulted in measurable success at the cellular and brain level, but more modest efficacy in eliciting a startle response from the mice.

TMC1 and TMC2 both encode channels in the microvilli of the inner ear's sensory hair cells. In response to movement generated by sound waves, the channels open, which results in the generation of an electrical signal that ultimately travels to the brain. Because they play such a central role in hearing, when the genes are missing or defective, this leads to deafness.

In the future, the researchers hope the technique developed in this study can be used with other genes that cause hereditary deafness. Dr Holt said: 'I can envision patients with deafness having their genome sequenced and a tailored, precision-medicine treatment injected into their ears to restore hearing.'

Clinical trials are likely to be five to ten years down the line, with more work needed to translate the gene therapy technique into humans. However, there is optimism in the field with Professor Tobias Moser of the University Medical Center Gottingen telling Reuters: 'It's an exciting time for gene therapy in hearing.'

SOURCES & REFERENCES
Reuters | 08 July 2015
 
The Independent | 08 July 2015
 
Eurekalert (press release) | 08 July 2015
 
New Scientist | 08 July 2015
 
Science Translational Medicine | 08 July 2015
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

16 October 2017 - by Dr Greg Ball 
Researchers have discovered 52 new genes essential for hearing in mice...
27 February 2017 - by Caroline Casey 
Scientists have developed a way of growing thousands of human hair cells – sensors in the inner ear that detect sound – from stem cells...
13 February 2017 - by Jamie Rickman 
An improved gene-therapy technique using a synthetic virus has restored the hearing of deaf mice up to the level of a whisper...
06 February 2017 - by Caroline Casey 
A novel gene therapy technique has partially restored hearing and balance in deaf mice...
24 August 2015 - by Antony Blackburn-Starza 
An experimental form of gene therapy to treat blindness has been showed to restore some vision in mice....

28 April 2014 - by Ruth Retassie 
Gene therapy, performed using cochlear implants, has regenerated auditory nerves in guinea pigs, a study reports...
11 February 2013 - by Reuben Harwood 
A short strip of genetic material has been used to prevent hereditary deafness in mice...
08 October 2012 - by Dr Sarah Spain 
US researchers have identified a genetic mutation responsible for the hearing loss that occurs with the condition Usher syndrome type I...
17 September 2012 - by Dr Greg Ball 
Stem cells have been used to partially restore hearing in deaf gerbils through replacement of their auditory nerve cells...
17 May 2010 - by Kyrillos Georgiadis 
US Scientists have produced mouse inner ear hair cells using stem cells, paving the way for a cure for deafness and other related balance disorders...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation